blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1407766

EP1407766 - Pharmaceutical compositions that contain a salt of alendronic acid [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.05.2010
Database last updated on 02.09.2024
Most recent event   Tooltip07.10.2011Lapse of the patent in a contracting state
New state(s): CY, TR		published on 09.11.2011  [2011/45]
Applicant(s)For all designated states
Verisfield (UK) Ltd.
Kerassountos Street 14
115 28 Athens / GR
[2009/01]
Former [2008/39]For all designated states
Verisfield (UK) Ltd.
120 East Road
London, N1 6AA / GB
Former [2004/16]For all designated states
Verisfield (UK) Ltd.
120 East Road
London, N1 6AA / GB
Inventor(s)01 / Pantazopoulou, Myrsini
57 C Syrou
Athens / GR
 [2004/16]
Application number, filing date03386023.003.10.2003
[2004/16]
Priority number, dateGR2002010043607.10.2002         Original published format: GR 2002100436
[2004/16]
Filing languageEL
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1407766
Date:14.04.2004
Language:EN
[2004/16]
Type: A3 Search report 
No.:EP1407766
Date:28.04.2004
[2004/18]
Type: B1 Patent specification 
No.:EP1407766
Date:01.07.2009
Language:EN
[2009/27]
Search report(s)(Supplementary) European search report - dispatched on:EP11.03.2004
ClassificationIPC:A61K9/16, A61K9/20, A61K9/00, A61K31/663
[2004/18]
CPC:
A61K31/663 (EP); A61K9/1623 (EP); A61K9/1652 (EP);
A61K9/2018 (EP); A61K9/2059 (EP)
Former IPC [2004/16]A61K9/16, A61K9/20, A61K31/663
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   RO,   SE,   SI,   SK,   TR [2004/16]
Extension statesAL07.10.2004
LT07.10.2004
LV07.10.2004
MK07.10.2004
TitleGerman:Pharmazeutische Zusammensetzungen mit einem Salz von Alendronsäure[2004/16]
English:Pharmaceutical compositions that contain a salt of alendronic acid[2004/16]
French:Compositions pharmaceutiques contenant un sel d'acide alendronique[2004/16]
Examination procedure07.10.2004Examination requested  [2005/01]
07.03.2005Despatch of a communication from the examining division (Time limit: M04)
20.06.2005Reply to a communication from the examining division
08.07.2005Despatch of a communication from the examining division (Time limit: M04)
10.08.2005Reply to a communication from the examining division
09.09.2008Fee for grant paid
09.09.2008Fee for publishing/printing paid
03.12.2008Communication of intention to grant the patent
Opposition(s)06.04.2010No opposition filed within time limit [2010/23]
Fees paidRenewal fee
13.12.2005Renewal fee patent year 03
19.10.2006Renewal fee patent year 04
25.10.2007Renewal fee patent year 05
02.10.2008Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
31.10.200503   M06   Fee paid on   13.12.2005
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT01.07.2009
BE01.07.2009
CY01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
IT01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
TR01.07.2009
BG01.10.2009
GR02.10.2009
GB03.10.2009
IE03.10.2009
LU03.10.2009
ES12.10.2009
CH31.10.2009
LI31.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
HU02.01.2010
[2011/44]
Former [2011/31]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
IT01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
GR02.10.2009
GB03.10.2009
IE03.10.2009
LU03.10.2009
ES12.10.2009
CH31.10.2009
LI31.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
HU02.01.2010
Former [2011/21]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
IT01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
GR02.10.2009
GB03.10.2009
IE03.10.2009
LU03.10.2009
ES12.10.2009
CH31.10.2009
LI31.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
Former [2011/14]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
IT01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
GR02.10.2009
GB03.10.2009
IE03.10.2009
ES12.10.2009
CH31.10.2009
LI31.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
Former [2011/01]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
GR02.10.2009
GB03.10.2009
IE03.10.2009
ES12.10.2009
CH31.10.2009
LI31.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
Former [2010/46]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
GR02.10.2009
IE03.10.2009
ES12.10.2009
CH31.10.2009
LI31.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
Former [2010/35]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
ES12.10.2009
MC31.10.2009
FR02.11.2009
PT02.11.2009
Former [2010/25]AT01.07.2009
BE01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
ES12.10.2009
MC31.10.2009
PT02.11.2009
Former [2010/23]AT01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
SK01.07.2009
BG01.10.2009
ES12.10.2009
PT02.11.2009
Former [2010/22]AT01.07.2009
CZ01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
RO01.07.2009
SE01.07.2009
SI01.07.2009
BG01.10.2009
ES12.10.2009
PT02.11.2009
Former [2010/20]AT01.07.2009
DK01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
SE01.07.2009
SI01.07.2009
BG01.10.2009
ES12.10.2009
PT02.11.2009
Former [2010/18]AT01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
SE01.07.2009
SI01.07.2009
BG01.10.2009
ES12.10.2009
PT02.11.2009
Former [2010/16]AT01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
SE01.07.2009
SI01.07.2009
ES12.10.2009
PT02.11.2009
Former [2010/10]AT01.07.2009
EE01.07.2009
FI01.07.2009
NL01.07.2009
SE01.07.2009
SI01.07.2009
ES12.10.2009
Former [2010/09]AT01.07.2009
EE01.07.2009
FI01.07.2009
SE01.07.2009
SI01.07.2009
ES12.10.2009
Former [2010/08]AT01.07.2009
EE01.07.2009
SE01.07.2009
SI01.07.2009
ES12.10.2009
Former [2009/51]SI01.07.2009
Documents cited:Search[A]US5462932  (BRENNER GERALD S [US], et al) [A] 1-10* claim - *;
 [A]WO0185176  (INST FARMACEUTYCZNY [PL], et al) [A] 1-10 * claim - * * example - * * page 5, line 13 - page 6, line 3 *;
 [A]WO0203963  (LECIVA A S [CZ], et al) [A] 1-10 * claim - * * examples 2-5,7 * * page 15; table TABLE * * page 18, paragraph B * * page 19; table TABLE * * page 12, line 5 - line 13 * * page 13, line 3 - line 10 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.